Frontotemporal dementia trials in Canada
13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleTrial of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease or Primary Tauopathies
- Where
- East York, Montreal, Toronto
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Arrowhead Pharmaceuticals
See details and how to joinNCT07221344 - No phaseTaking peopleARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- Where
- Toronto, Vancouver
- Age
- 18 years and over
- People
- 2,100 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT04363684 - No phaseEnrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4
- Where
- London, Toronto, Vancouver
- Age
- 55 years to 90 years
- People
- 1,500 worldwide
- Run by
- University of Southern California
See details and how to joinNCT05617014 - No phaseTaking peopleEffects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients
- Where
- Fredericton, Montreal, Saskatoon
- Age
- 18 years and over
- People
- 150
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT06051123 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
- Where
- Toronto
- Age
- 30 years to 75 years
- People
- 18 worldwide
- Run by
- AviadoBio Ltd
See details and how to joinNCT06064890 · EU 2023-509444-10-00 - Phase 2Taking peopleTranscranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
- Where
- Toronto
- Age
- 50 years to 90 years
- People
- 180 worldwide
- Run by
- Johns Hopkins University
See details and how to joinNCT05386394 - No phaseTaking peopleComprehensive Assessment of Neurodegeneration and Dementia
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Peterborough, Québec, Sherbrooke, Toronto, Vancouver, Victoria, Waterloo
- Age
- 50 years to 90 years
- People
- 1,573
- Run by
- McGill University
See details and how to joinNCT03402919 - No phaseTaking peopleImproving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
- Where
- North York, Toronto
- Age
- 30 years to 95 years
- People
- 500
- Run by
- University Health Network, Toronto
See details and how to joinNCT06529744 - No phaseTaking peopleGenetic Frontotemporal Dementia Initiative for Neurodevelopment
- Where
- London
- Age
- 7 years to 17 years
- People
- 200
- Run by
- Western University
See details and how to joinNCT05779813 - No phaseTaking peopleDiagnosing Frontotemporal Lobar Degeneration
- Where
- Toronto
- Age
- 18 years to 90 years
- People
- 100
- Run by
- University Health Network, Toronto
See details and how to joinNCT02964637 - No phaseTaking peopleMolecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
- Where
- London
- Age
- 30 years to 95 years
- People
- 40
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT02945774 - No phaseTaking peopleInvestigating Genetic Status in Patients Presenting to Clinic
- Where
- London
- Age
- 18 years and over
- People
- 1,000
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT05911932 - Phase 4Taking peopleLemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
- Where
- Halifax
- People
- 1
- Run by
- Nova Scotia Health Authority
See details and how to joinNCT06093126